Vanda Pharmaceuticals Inc... (VNDA)
undefined
undefined%
At close: undefined
4.64
1.08%
After-hours Dec 13, 2024, 05:18 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Revenue 192.64M 254.38M 268.68M 248.17M 227.19M 193.12M 165.08M 146.02M 109.92M 50.16M 33.88M 32.73M 31.27M 35.22M 4.55M - - - - 33.98K
Cost of Revenue 14.80M 24.28M 25.63M 23.36M 24.49M 20.51M 17.85M 24.71M 23.46M 1.58M - 129.00K - 4.39M 2.90M - - - - -
Gross Profit 177.84M 230.10M 243.05M 224.80M 202.70M 172.61M 147.24M 121.31M 86.46M 48.57M 33.88M 32.60M 31.27M 30.83M 1.65M - - - - 33.98K
Operating Income -13.95M 6.33M 42.16M 27.24M 22.81M 21.74M -16.90M -18.57M -40.19M 20.06M -20.40M -28.23M -10.71M 8.35M -35.95M -52.85M -80.04M -65.71M -24.29M -9.53M
Interest Income - - 199.00K 4.42M 6.22M - - - - - - - 461.00K 431.00K 89.10K 1.78M 5.91M 2.20B - -
Pretax Income 6.34M 11.30M 42.36M 31.66M 29.03M 25.35M -15.43M -17.91M -39.87M 20.19M -20.25M -27.66M -10.25M 9.27M -35.86M -51.06M -74.06M -63.51M -23.88M -9.47M
Net Income 2.51M 6.28M 33.15M 23.34M 115.55M 25.21M -15.57M -18.01M -39.87M 20.19M -20.25M -27.66M -9.80M 7.19M -35.86M -51.06M -74.07M -63.51M -23.88M -9.47M
Selling & General & Admin 112.88M 136.49M 124.05M 140.51M 129.74M 105.75M 123.84M 99.79M 84.53M 84.64M 24.59M 13.88M 11.49M 10.15M 23.72M 28.91M 32.80M 13.64M 7.40M 2.12M
Research & Development 76.82M 85.77M 75.36M 55.58M 48.65M 43.59M 38.55M 29.16M 29.14M 19.23M 28.19M 45.45M 29.00M 12.34M 13.87M 23.94M 47.23M 52.07M 16.89M 7.44M
Other Expenses 2.09M 1.52M 1.48M 1.48M 1.50M 3.61M 1.47M 665.00K 320.00K 124.00K 145.00K 561.00K 1.50M 1.50M - - - - - -
Operating Expenses 191.80M 223.77M 200.89M 197.56M 179.89M 150.87M 164.14M 139.88M 126.65M 106.13M 54.28M 60.82M 41.98M 22.48M 37.60M 52.85M 80.04M 65.71M 24.29M 9.56M
Interest Expense - - - - - - - - - - - - - - 97.00 - - 4.83K - -
Selling & Marketing Expenses 500.00K 2.60M 6.70M 12.60M 3.20M 900.00K 1.30M 1.40M 3.40M 5.00M - - - - - - - - - -
Cost & Expenses 206.59M 248.05M 226.52M 220.93M 204.38M 171.38M 181.99M 164.59M 150.11M 107.71M 54.28M 60.95M 41.98M 26.87M 40.50M 52.85M 80.04M 65.71M 24.29M 9.56M
Income Tax 3.83M 5.03M 9.21M 8.32M -86.53M 138.00K 136.00K 104.00K - -77.62M - - -444.00K 2.08M - 1.78M 9.88K 549.00 7.65K 4.95K
Shares Outstanding (Basic) 57.38M 56.46M 55.55M 54.43M 53.14M 50.86M 44.48M 43.45M 42.25M 34.77M 30.35M 28.23M 28.11M 27.92M 27.02M 26.65M 26.36M 16.00M 21.91M 469.97M
Shares Outstanding (Diluted) 57.56M 56.98M 56.92M 55.19M 54.85M 53.05M 44.74M 43.45M 42.25M 36.69M 30.35M 28.23M 28.11M 28.53M 27.02M 26.65M 26.36M 16.00M 21.91M 469.97M
EPS (Basic) 0.04 0.11 0.60 0.43 2.17 0.50 -0.35 -0.41 -0.94 0.58 -0.67 -0.98 -0.35 0.26 -1.33 -1.92 -2.81 -3.97 -1.09 -0.02
EPS (Diluted) 0.04 0.11 0.58 0.42 2.11 0.48 -0.35 -0.41 -0.94 0.55 -0.67 -0.98 -0.35 0.25 -1.33 -1.92 -2.81 -3.97 -1.09 -0.02
EBITDA -10.94M 9.06M 45.01M 30.10M 25.70M 24.69M -13.92M -6.70M -26.63M -54.77M -19.27M -27.05M -9.67M 10.67M -34.52M -50.53M -73.49M -62.93M -23.43M -9.15M
Depreciation & Amortization 3.01M 2.73M 2.84M 2.86M 2.89M 2.96M 2.98M 11.87M 12.97M 2.25M 1.50M 1.50M 1.50M 1.83M 1.42M 530.80K 571.59K 575.37K 423.83K 376.71K